Jun-ichi Kamata

发表

Synthesis and evaluation of novel pyrimido-acridone, -phenoxadine, and -carbazole as topoisomerase II inhibitors.

T. Nagasu, Jun-ichi Kamata, Toshimi Okada, 2004, Chemical & pharmaceutical bulletin.

Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor

D. Ito, K. Sawada, K. Miyazaki, 2011, International journal of molecular medicine.

Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor.

T. Nagasu, Jun-ichi Kamata, Toshimi Okada, 2002, Molecular cancer therapeutics.

Endothelium 2 Subunit on α Inhibitor Suppressing an Expression of Integrin Sulfonamide Derivative , E 7820 , Is a Unique Angiogenesis

T. Owa, Yuji Yamamoto, Keiko Takahashi, 2002 .

Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium.

T. Owa, Yuji Yamamoto, Keiko Takahashi, 2002, Cancer research.

A novel carbazole topoisomerase II poison, ER‐37328: potent tumoricidal activity against human solid tumors in vitro and in vivo

T. Nagasu, Jun-ichi Kamata, Toshimi Okada, 2003, Cancer science.

Synthesis and structure-activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors.

D. Ito, K. Miyazaki, K. Okamoto, 2014, Bioorganic & medicinal chemistry.

The total synthesis of rifamycin W

M. Nakata, K. Tatsuta, Jun-ichi Kamata, 1990 .

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage

Z. Dezső, Yuji Yamamoto, Keiko Takahashi, 2014, Vascular cell.

Synthesis and evaluation of novel pyrimido-acridone, -phenoxadine, and -carbazole as topoisomerase II inhibitors.

T. Nagasu, Jun-ichi Kamata, Toshimi Okada, 2004, Chemical & pharmaceutical bulletin.